Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Biotech
Syneron closes $150M round to support peptide platform
Peptide drug discovery company Syneron Bio closed a $150 million series B round to support its macrocyclic peptide development platform.
Will Maddox
Apr 3, 2026 9:31am
ADCs, TCEs among ‘exciting things’ on Boehringer's shopping list
Apr 3, 2026 8:40am
Carl Sailer on AI, market trends, and strategic planning in biotech
Brought to you by
Syneos Health
Bayer radiology head takes top U.S. pharma spot—Chutes & Ladders
Apr 3, 2026 8:30am
Guidehouse’s Karla Anderson shares top tips for successful biotech commercialization
Brought to you by
Guidehouse
Biopharma R&D pipeline shrinks for 1st time in 30 years: report
Apr 3, 2026 8:13am
